ClinicalTrials.gg
RecruitingNCT07048561Updated Nov 12, 2026

Health-related Physical Fitness and Executive Function in Older Adults: A Prospective Study

An observational study in Older Adults (65 Years and Older), Fitness Testing and Executive Function (Cognition), sponsored by National Taiwan Normal University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by National Taiwan Normal University · Observational

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Updated Nov 12, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to explore the relationship between health-related physical fitness and behavioural and electrophysiological aspects of cool and hot executive function in older adults through a year prospective study design. The main questions it aims to answer whether changes in health-related physical fitness will positively predict changes in behavioural and electrophysiological aspects of cool and hot executive functions in older adults. The participants will be asked to complete pre-test, a one-year observation period, and post-test. Both pre- and post-tests will measure health-related physical fitness, executive function, and various demographic variables and covariates. Health-related physical fitness assessments include cardiorespiratory endurance (YMCA submaximal cycle test), muscular strength (grip strength, chest press, and leg press), muscular endurance (30-second chair stand, 30-second bicep curl), flexibility (range of motion), and balance (Balance Error Scoring System). Executive function will be measured using the Stroop test and emotional Stroop test, with concurrent EEG recording of brain activity. Demographic variables and covariates include sex, age, years of education, annual income, Pittsburgh Sleep Quality Index (PSQI), International Physical Activity Questionnaire (IPAQ) Taiwan short form, World Health Organisation Quality of Life Brief Assessment (WHOQOL-BREF) Taiwan version, Geriatric Depression Scale, Mini-Mental State Examination (MMSE), digit span tests, and step count recorded by mobile phones or watches over the previous month, resting heart rate, and resting blood pressure. No interventions will be conducted during the one-year observation period, maintaining participants' normal daily living conditions.

Read the detailed description

Executive function refers to higher-order cognitive functions responsible for planning, organisation, and problem-solving. These functions decline with age and are crucial for maintaining independence and quality of life in older adults. Research indicates that health-related physical fitness may serve as a protective factor against executive function decline, encompassing cardiorespiratory endurance, body composition, muscular strength, muscular endurance, flexibility, and balance. However, no studies have simultaneously tracked the relationship between these health-related physical fitness components and executive function. Thus, this study employs a one-year prospective design to investigate the relationship between changes in health-related physical fitness and executive function in older adults. The study will recruit 200 older adults aged 65 or above for pre-test, a one-year observation period, and post-test. Both pre- and post-tests will measure health-related physical fitness, executive function, and various demographic variables and covariates. Health-related physical fitness assessments include cardiorespiratory endurance (YMCA submaximal cycle test), muscular strength (grip strength, chest press, and leg press), muscular endurance (30-second chair stand, 30-second bicep curl), flexibility (range of motion), and balance (Balance Error Scoring System). Executive function will be measured using the Stroop test and emotional Stroop test, with concurrent EEG recording of brain activity. Demographic variables and covariates include sex, age, years of education, annual income, Pittsburgh Sleep Quality Index (PSQI), International Physical Activity Questionnaire (IPAQ) Taiwan short form, World Health Organisation Quality of Life Brief Assessment (WHOQOL-BREF) Taiwan version, Geriatric Depression Scale, Mini-Mental State Examination (MMSE), digit span tests, and step count recorded by mobile phones or watches over the previous month, resting heart rate, and resting blood pressure. No interventions will be conducted during the one-year observation period, maintaining participants' normal daily living conditions. This study will provide preliminary evidence on the relationship between health-related fitness and executive function, offering guidance to the public and government agencies for developing exercise programmes aimed at enhancing executive function. By understanding key health-related physical fitness components for exercise design, Taiwan, which faces an ageing society, may potentially reduce government financial and social burdens related to dementia care.

02

Conditions studied

  • Older Adults (65 Years and Older)
  • Fitness Testing
  • Executive Function (Cognition)
  • Prospective Study
  • Event-Related Potentials
03

In context

Lead sponsor

National Taiwan Normal University is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Study population are older adults aged 65 or above.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 65 or above.
  • Able to engage in fitness testing.
  • Normal vision or corrected-to-normal vision.

Exclusion criteria

Exclusion Criteria:

  • Suffering from cardiopulmonary-related diseases.
  • Suffering from cognitive, neurological or psychiatric disorders (e.g., dementia, Parkinson's disease, epilepsy, depression, schizophrenia, etc.).
  • Suffering from infectious diseases (e.g., hepatitis, or Creutzfeldt-Jakob disease).
  • Having a history of drug or alcohol abuse.
  • Having colour vision deficiency (e.g., colour blindness).
  • Having a family history of aneurysm.
  • Taking medications that affect brain function.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Older adults

    Older adults aged 65 and above.

    Other: observation alone

Interventions

  • Otherobservation alone

    No interventions will be conducted during the one-year observation period, maintaining participants' normal daily living conditions.

    Also known as: one-year observation

06

What researchers measure

Primary outcomes

  1. Health-related physical fitness (cardiorespiratory endurance)

    Cardiorespiratory endurance was assessed using the YMCA Submaximal Cycle Ergometer Test. The protocol comprised four 3-minute stages at 50 rpm, beginning with a 25W workload in stage one. Stage two workload was determined by steady-state heart rate (HR) achieved during the final two minutes of stage one (tolerance ±5 beats/min): \<80 beats/min = 125W; 80-89 beats/min = 100W; 90-100 beats/min = 75W; \>100 beats/min = 50W. Stages three and four increased workload by 25W increments, targeting two consecutive steady-state HRs between 110 beats/min and 85% HRmax. Stage duration was extended by one-minute intervals when steady-state criteria were not met (HR variation \>5 beats/min or \<110 beats/min during final two minutes). Peak VO₂ was estimated using established formulae.

    Time frame: From enrolment to the end of observation at one year.

  2. Health-related physical fitness (muscular strength)

    Muscular strength was assessed by handgrip strength, chest press, and leg press. Hand grip strength was assessed using a digital hand dynamometer. Chest and leg press was assessed using chest and leg press machines, respectively, following a standardised four-stage protocol. Participants initially performed 10-12 repetitions at minimal resistance for familiarisation and warm-up. Subsequently, they completed 5-10 repetitions with progressively increasing resistance (5-10% increments for upper body; 10-20% for lower body), with 3-5 minute rest intervals between attempts. This process continued until participants could perform fewer than five repetitions. The final successfully completed workload served as the basis for one-repetition maximum (1-RM) estimation using established conversion tables.

    Time frame: From enrolment to the end of observation at one year.

  3. Health-related physical fitness (muscular endurance)

    Muscular endurance was assessed using the 30-second bicep curl and 30-second chair stand from the Senior Fitness Test. The 30-second bicep curl required participants to sit upright on the chair edge, favouring their dominant side, with feet flat on the ground. Using a handshake grip, they held a dumbbell (5 pounds for females, 8 pounds for males) in their dominant hand, with the arm initially hanging straight down beside the chair. Complete arm flexion and extension constituted one repetition, with participants instructed to perform maximal repetitions within 30 seconds. The 30-second chair stand required participants to sit centrally with backs straight, feet flat on the ground, and arms crossed over their chests. They performed maximal repetitions of standing up and sitting down within 30 seconds. The total number of repetitions in each test served as the respective muscular endurance indicator.

    Time frame: From enrolment to the end of observation at one year.

  4. Health-related physical fitness (flexibility)

    Flexibility was assessed using range of motion measurements obtained with a joint goniometer. The goniometer's fulcrum was positioned at the centre of the target joint, with arms aligned to the bony landmarks of the proximal and distal segments. The resulting angular measurement represented the joint's range of motion.

    Time frame: From enrolment to the end of observation at one year.

  5. Health-related physical fitness (balance)

    Balance was assessed using the Balance Error Scoring System (BESS). Participants maintained six stances for 20 seconds each with eyes closed and hands on hips: double-leg stance, single-leg stance on the non-dominant foot, and tandem stance with the non-dominant heel against the dominant toe. These three positions were performed on both a firm surface and a medium-density foam pad (45 cm × 45 cm × 13 cm). Errors were recorded for removing hands from hips, opening eyes, stepping, excessive hip movement (\>30°), or lifting the foot. Each trial was scored with a maximum of 10 errors, with participants unable to maintain stance for 5 seconds receiving the maximum score. The total BESS score represented cumulative errors across all six conditions.

    Time frame: From enrolment to the end of observation at one year.

  6. Executive function

    Executive function will be measured using the Stroop test and emotional Stroop test, with concurrent EEG recording of brain activity.

    Time frame: From enrolment to the end of observation at one year.

Secondary outcomes

  1. Demographic questionnaire

    Demographic questionnaire include sex, age, years of education, and step count recorded by mobile phones or watches over the previous month.

    Time frame: From enrolment to the end of observation at one year.

  2. Sleep quality (Pittsburgh Sleep Quality Index, PSQI)

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-report questionnaire comprising 19 items that evaluate sleep patterns over the preceding month. The instrument generates seven component scores: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, sleep medication use, and daytime dysfunction. Each component is scored from 0 to 3, yielding a global score ranging from 0 to 21. Scores ≤5 indicate good sleep quality, whilst scores \>5 suggest poor sleep quality, with higher values reflecting greater sleep impairment.

    Time frame: From enrolment to the end of observation at one year.

  3. Physical activity (Taiwan version of the International Physical Activity Questionnaire, IPAQ)

    Physical activity was assessed using the Taiwan version of the International Physical Activity Questionnaire (IPAQ). This seven-item instrument measures metabolic equivalents (METs) across work, household, leisure, and sedentary activities over a seven-day period, expressed in kcal/kg/min. Activities are categorised as vigorous, moderate, and light intensity (walking), alongside sedentary behaviour, with frequency (days/week) and duration (minutes/session) recorded for each intensity level.

    Time frame: From enrolment to the end of observation at one year.

  4. Quality of life (Taiwan version of World Health Organisation Quality of Life Brief Assessment, WHOQOL-BREF)

    Quality of life was assessed using the Taiwan version of the World Health Organization Quality of Life Questionnaire-Brief Form (WHOQOL-BREF), a validated 24-item instrument utilising a five-point Likert scale. Participants evaluated their experiences and perceptions over the preceding two weeks across four domains: physical health, psychological health, social relationships, and environmental factors. Two additional items assessed overall quality of life and general health satisfaction. This instrument provides comprehensive multidimensional assessment suitable for clinical and research applications.

    Time frame: From enrolment to the end of observation at one year.

  5. Depressive symptoms (Geriatric Depression Scale)

    The Geriatric Depression Scale (GDS-15) comprises 15 items designed to assess depressive symptoms in older adults. Scores range from 0-15, with higher values indicating greater depressive symptomatology. Clinical cut-off points are established as follows: scores of 0-4 indicate normal mood, 5-8 suggest mild depression, 9-11 indicate moderate depression, and scores ≥12 suggest severe depression.

    Time frame: From enrolment to the end of observation at one year.

  6. Cognitive function (Mini-Mental State Examination, MMSE)

    The Mini-Mental State Examination (MMSE) is a widely utilised cognitive screening instrument that provides quantitative assessment of cognitive function. This 30-item assessment evaluates multiple cognitive domains: orientation (10 points), memory encoding (3 points), attention and calculation (5 points), recall (3 points), and language with visuospatial construction (9 points). Total scores range from 0 to 30, with scores below 25 indicating potential cognitive impairment.

    Time frame: From enrolment to the end of observation at one year.

  7. Working memory (Digit Span Tests)

    Working memory was assessed using the Digit Span subtest from the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). The subtest comprises forward digit sequences (16 items) and backward digit sequences (14 items), administered orally without written aids. Participants were required to reproduce number sequences verbally, either in the original order (forward condition) or in reverse order (backward condition). Each correct response received one point, yielding maximum possible scores of 16 and 14 points for the forward and backward conditions, respectively.

    Time frame: From enrolment to the end of observation at one year.

  8. Resting heart rate

    Resting heart rate was measured using the Polar H10 chest-worn heart rate monitor. Participants were seated in a quiet, temperature-controlled environment for a minimum of five minutes prior to measurement to ensure cardiovascular stabilisation. Heart rate data were recorded continuously over a three-minute period.

    Time frame: From enrolment to the end of observation at one year.

  9. Resting blood pressure

    Resting blood pressure was assessed using an automated oscillometric sphygmomanometer. Measurements were taken from the participant's non-dominant arm following a standardised protocol, with participants seated upright and feet flat on the floor.

    Time frame: From enrolment to the end of observation at one year.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2025 (actual). Primary completion is estimated for Jul 2027, 25 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Mar 2027 → Jul 2027 and completion Mar 2027 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 21, 2025
First posted
Jul 2, 2025
StartActual
Jun 1, 2025
Primary completionEst.
Jul 31, 2027was Mar 2027
CompletionEst.
Jul 31, 2027was Mar 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 31, 2027→Jul 31, 2027
Nov 12, 2026
Study completion
Mar 31, 2027→Jul 31, 2027
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Mar 31, 2027→Jul 31, 2027
    Study completion Mar 31, 2027→Jul 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07048561
Lead sponsor
National Taiwan Normal University
Responsible party
Ruei-Hong Li (Doctoral student, National Taiwan Normal University) — Principal investigator
First posted
Jul 2, 2025
Start date
Jun 1, 2025
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Ruei-Hong Li, MS
Contact
rueihongli@gmail.com
+886-988163220
Yu-Kai Chang, PhD
study director · National Taiwan Normal University
Ruei-Hong Li, MS
principal investigator · National Taiwan Normal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion